5.40 LONG-TERM EFFICACY AND SAFETY OF EXTENDED-RELEASE MOLINDONE (SPN-810) TO MANAGE IMPULSIVE AGGRESSION IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Hyperactivity Disorder ◽

Term Efficacy ◽

Impulsive Aggression

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.218 ◽

2016 ◽

Vol 55 (10) ◽

pp. S170

Author(s):

Valerie K. Arnold ◽

Norberto J. DeSousa ◽

Bev Incledon ◽

Floyd R. Sallee ◽

Timothy E. Wilens ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Pivotal Phase ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder ◽

Delayed Release

A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.05.021 ◽

2020 ◽

Vol 42 (8) ◽

pp. 1452-1466 ◽

Cited By ~ 2

Author(s):

Azmi Nasser ◽

Tesfaye Liranso ◽

Toyin Adewole ◽

Nicholas Fry ◽

Joseph T. Hull ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Controlled Trial ◽

Phase Iii ◽

School Age Children ◽

School Age ◽

Efficacy And Safety ◽

Once Daily ◽

Long-Term Effects of Extended-Release Mixed Amphetamine Salts Treatment of Attention- Deficit/Hyperactivity Disorder on Growth

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2005.15.191 ◽

2005 ◽

Vol 15 (2) ◽

pp. 191-202 ◽

Cited By ~ 56

Author(s):

Stephen V. Faraone ◽

Joseph Biederman ◽

Michael Monuteaux ◽

Thomas Spencer

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Long Term Effects ◽

EPA-0666 – Long-term maintenance of efficacy of extended-release guanfacine hydrochloride (GXR) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): double-blind, placebo-controlled, multicentre, phase 3 randomized withdrawal study

European Psychiatry ◽

10.1016/s0924-9338(14)78034-4 ◽

2014 ◽

Vol 29 ◽

pp. 1 ◽

Cited By ~ 3

Author(s):

J. Newcorn ◽

V. Harpin ◽

M. Huss ◽

M. Johnson ◽

J.A. Ramos-Quiroga ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Hyperactivity Disorder ◽

Term Maintenance

A Randomized, 3-Phase, 34-Week, Double-Blind, Long-Term Efficacy Study of Osmotic-Release Oral System-Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

Journal of Clinical Psychopharmacology ◽

10.1097/jcp.0b013e3181ee84a7 ◽

2010 ◽

Vol 30 (5) ◽

pp. 549-553 ◽

Cited By ~ 43

Author(s):

Joseph Biederman ◽

Eric Mick ◽

Craig Surman ◽

Robert Doyle ◽

Paul Hammerness ◽

...

Keyword(s):

Attention Deficit ◽

Efficacy Study ◽

Double Blind ◽

Hyperactivity Disorder ◽

Term Efficacy

Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison

European Child & Adolescent Psychiatry ◽

10.1007/s00787-017-0962-6 ◽

2017 ◽

Vol 26 (8) ◽

pp. 875-897 ◽

Cited By ~ 13

Author(s):

Alain Joseph ◽

Rajeev Ayyagari ◽

Meng Xie ◽

Sean Cai ◽

Jipan Xie ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Mixed Treatment Comparison ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Hyperactivity Disorder ◽

Treatment Comparison ◽

Mixed Treatment

6.9 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2017.09.354 ◽

2017 ◽

Vol 56 (10) ◽

pp. S278-S279

Author(s):

Ann Childress ◽

Sally Berry ◽

Antonio Pardo ◽

Heidi W. Belden

Keyword(s):

Pilot Study ◽

Attention Deficit ◽

Early Onset ◽

Extended Release ◽

Oral Suspension ◽

Efficacy And Safety ◽

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.02.011 ◽

2006 ◽

Vol 28 (2) ◽

pp. 266-279 ◽

Cited By ~ 64

Author(s):

Thomas J. Spencer ◽

Timothy E. Wilens ◽

Joseph Biederman ◽

Richard H. Weisler ◽

Stephanie C. Read ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Parallel Group Study ◽

Parallel Group ◽

Adolescent Patients

Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1097/01.chi.0000220847.41027.5d ◽

2006 ◽

Vol 45 (7) ◽

pp. 817-823 ◽

Cited By ~ 41

Author(s):

LAURENCE L. GREENHILL ◽

RAFAEL MUNIZ ◽

ROBERTA R. BALL ◽

ALAN LEVINE ◽

LINDA PESTREICH ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study

BMC Psychiatry ◽

10.1186/s12888-020-02965-7 ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Akira Iwanami ◽

Kazuhiko Saito ◽

Masakazu Fujiwara ◽

Daiki Okutsu ◽

Hironobu Ichikawa

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Extension Study ◽

Open Label ◽

Phase 3 ◽

Safety And Efficacy ◽

An amendment to this paper has been published and can be accessed via the original article.